Evolus EOLS
NASDAQ EOLS
$7.62 +0.20 (+2.69%)
As of: Nov 12, 2026 · 12:43 PM EST

Evolus (EOLS) Interest & Investment Income (2018 - 2026)

Updated

Evolus (EOLS) recorded Interest & Investment Income of $296,000 in Q3 2026, down 38.2% from $479,000 a year earlier and unchanged from the prior quarter.

Analysis

Evolus (EOLS) Interest & Investment Income (2018 - 2026) Analysis & Trends

On a TTM basis, Evolus' Interest & Investment Income came in at $1.14 million as of Sep 30, 2026, down 53.6% year-over-year; for FY2025, it came in at $1.93 million, down 40.8% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $3.26 million in FY2024 (+279.4%), $860,000 in FY2023 (+622.7%), $119,000 in FY2022 and $1,000 in FY2021 (-99.8%).
  • Quarterly Interest & Investment Income has ranged from $4,000 in Q2 2022 to $1.03 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 12.0% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 705.3% in Q3 2023, against a decline of 66.7% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $296,000 (Q2 2026), $285,000 (Q1 2026) and $263,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Evolus 450.43 Mn 259.94 Mn 50.69 Mn 296,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 296,000.00
Jun 30, 2026 296,000.00
Mar 31, 2026 285,000.00
Dec 31, 2025 263,000.00
Sep 30, 2025 479,000.00
Jun 30, 2025 479,000.00
Mar 31, 2025 710,000.00
Dec 31, 2024 789,000.00
Sep 30, 2024 928,000.00
Jun 30, 2024 1.03 Mn
Mar 31, 2024 517,000.00
Dec 31, 2023 291,000.00
Sep 30, 2023 306,000.00
Jun 30, 2023 164,000.00
Mar 31, 2023 99,000.00
Dec 31, 2022 77,000.00
Sep 30, 2022 38,000.00
Jun 30, 2022 4,000.00
Jun 30, 2021 1,000.00
Dec 31, 2020 5,000.00
API Access

Evolus Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EOLS&period=max&api_key=YOUR_API_KEY